Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18882)

• Formulation Name: Ranolazine 1000 mg tablet
• Company: Gilead Sciences

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ranolazine	(DM0C9IL)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 3350	(E00652)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent